IKT Latest Press Releases

-- July 23, 2026 --

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH Globe Newswire 8:00 AM

-- July 14, 2026 --

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility Globe Newswire 8:00 AM

-- July 2, 2026 --

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- May 12, 2026 --

Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity Globe Newswire 4:01 PM

-- April 7, 2026 --

Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension Globe Newswire 8:00 AM

-- April 3, 2026 --

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 2:01 PM

-- March 26, 2026 --

Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software